The contract manufacturing market for live biotherapeutics and microbiome products
With over 85 microbiome-based, live biotherapeutic products under preclinical and clinical development, the demand for R&D and manufacturing services for such products is anticipated to increase beyond the capabilities of innovator companies alone
The STING pathway targeting technologies market, featuring a healthy pipeline of therapeutics, is anticipated to be worth over USD 2.8 billion by 2030
Roots Analysis is pleased to announce the publication of its recent study, titled, “STING Pathway Targeting Therapeutics and Technologies, 2020-2030.”
The “Cell and Advanced Therapies Supply Chain Management Market, 2020-2030”
To order this 510+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/cell-therapies-supply-chain/260.html
Growing at an annualized rate of over 9%, the antibody discovery services market is projected to be worth USD 6.5 billion
London Roots Analysis has announced the addition of “Antibody Discovery: Services and Platforms Market (3rd Edition), 2020-2030” report to its list of offerings.
The antibody drug conjugates market is estimated to be worth more than 15 billion in 2030, predicts Roots Analysis
Antibody drug conjugates (ADCs) represent a transformative approach to modern cancer treatment; over the years, this upcoming class of targeted therapeutic agents has generated significant enthusiasm within the medical science community
The opportunity for AR / VR based digital marketing service
Roots Analysis has announced the addition of “AR / VR based Healthcare Digital Marketing Service Providers Market, 2020-2030” report to its list of offerings.
The contract fill / finish services market for biologics is anticipated to be worth USD 4.2 billion by 2030
Roots Analysis is pleased to announce the publication of its recent study, titled, “Biologics Fill / Finish Services Market, 2019-2030.”
The biopharmaceutical contract manufacturing market is estimated to be worth USD 13.9 billion in 2030
Roots Analysis is pleased to announce the publication of its recent study, titled, “Biopharma Contract Manufacturing Market (3rd Edition), 2019-2030.”